Stock Taper
EARNINGS CALL ARCHIVE 4 CALLS ON FILE
BBNX — Beta Bionics, Inc.
NASDAQ
FULL STOCK PAGE →

Q2 2026 Earnings Call Summary

JUL 29, 2026
REVENUE
$32.0M +15.9%
NET MARGIN
-73.1% +6.2 PTS
EPS
-$0.53 -8.2%
FREE CASH FLOW
-$15.7M +37.9%

No summary has been written for this call yet.